GE HealthCare, Siemens Healthineers and Philips are working on generative AI products that aggregate patient data to make ...

The global intravascular imaging market is poised for significant expansion, with its valuation expected to rise from USD 387.8 million in 2023 to USD 656.29 million by 2033. This substantial growth, ...

The purchase of the shares of Siemens Healthineers AG is carried out by a credit institution that has been commissioned by Siemens Healthineers AG; the shares are repurchased exclusively on the ...

The firm's Innovance Antithrombin assay is used to monitor antithrombin activity levels in hemophilia patients and aid dosing decisions for a routine prophylaxis.

The antithrombin assay will support dosing Qfitlia, the sixth Alnylam-discovered RNAi medicine to receive FDA approval.

FDA approves Sanofi's Qfitlia, the first antithrombin-lowering therapy for hemophilia A or B, reducing bleeding episodes with ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Siemens Healthineers AG (SEMHF – Research ...

Siemens and Accenture (NYSE: ACN) are significantly advancing their long-standing alliance partnership to help clients reinvent and transform engineering and manufacturing. This press release features ...

One key area is the development of new technologies. Singapore General Hospital and Siemens Healthineers have signed a ...

Multinationals with significant operational footprints in Ireland, Germany, and Switzerland could bear the brunt of the Trump ...

Varian, a Siemens Healthineers company, announced a United States comarketing and sales agreement with Embolx for the Sniper ...